Cargando…

Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias

OBJECTIVE: To explore the cardiac electrophysiological characteristics of cardiac hypertrophy and its influence on the occurrence of ventricular tachyarrhythmias. METHODS: Adult C57BL6 mice were randomly divided into a surgery group and a control group. Thoracic aortic constriction was performed on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaowei, Qin, Mu, Jiang, Weifeng, Zhang, Yu, Liu, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580922/ https://www.ncbi.nlm.nih.gov/pubmed/28863155 http://dx.doi.org/10.1371/journal.pone.0183671

Ejemplares similares

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016)

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

Clinical and electrophysiological characteristics of ventricular arrhythmias arising from pulmonary cusps
por: Rangaswamy, Vickram V., et al.
Publicado: (2020)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload
por: WU, CHUNTAO, et al.
Publicado: (2015)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice
por: Hu, Chengyun, et al.
Publicado: (2022)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
por: Nordén, Einar Sjaastad, et al.
Publicado: (2021)

Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy
por: Jabbour, Andrew, et al.
Publicado: (2012)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Electrocardiographic and electrophysiological characteristics of idiopathic ventricular arrhythmias originating from the vicinity of tricuspid annulus
por: Yu, Manli, et al.
Publicado: (2021)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
por: Hao, Jia, et al.
Publicado: (2007)

MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
por: Ji, Yue, et al.
Publicado: (2018)

Protective Roles of Interferon‐γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload
por: Kimura, Akihiko, et al.
Publicado: (2018)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy via Activating AKT Signaling Pathway
por: Pang, Yanan, et al.
Publicado: (2021)

Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload
por: Németh, Balázs Tamás, et al.
Publicado: (2016)

Dysregulation of proangiogeneic factors in pressure-overload left-ventricular hypertrophy results in inadequate capillary growth
por: Zeriouh, Mohamed, et al.
Publicado: (2019)

Twenty-five years of research in cardiac imaging in electrophysiology procedures for atrial and ventricular arrhythmias
por: Berruezo, Antonio, et al.
Publicado: (2023)

Deciphering the Electrophysiological Mechanisms for Ibrutinib-Induced Ventricular Arrhythmias
por: Kudinov, Alex, et al.
Publicado: (2020)

Iron overload and arrhythmias: Influence of confounding factors
por: Shizukuda, Yukitaka, et al.
Publicado: (2019)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Effects of Estrogen, an ERα Agonist and Raloxifene on Pressure Overload Induced Cardiac Hypertrophy
por: Westphal, Christina, et al.
Publicado: (2012)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

Anacardic acid attenuates pressure‐overload cardiac hypertrophy through inhibiting histone acetylases
por: Li, Shuo, et al.
Publicado: (2019)

Nanoscale reorganization of sarcoplasmic reticulum in pressure-overload cardiac hypertrophy visualized by dSTORM
por: Hadipour-Lakmehsari, Sina, et al.
Publicado: (2019)

Thymoquinone ameliorates pressure overload‐induced cardiac hypertrophy by activating the AMPK signalling pathway
por: Chen, Heng, et al.
Publicado: (2021)

YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload
por: Kashihara, Toshihide, et al.
Publicado: (2022)

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
por: Tojima, Mikuto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h2mp5t7ngqihff093pc98oqoce